Idexx Laboratories (IDXX) Shares Outstanding (Weighted Average) (2016 - 2025)
Idexx Laboratories has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $80.4 million for Q4 2025.
- Quarterly results put Shares Outstanding (Weighted Average) at $80.4 million for Q4 2025, down 2.47% from a year ago — trailing twelve months through Dec 2025 was $80.4 million (down 2.47% YoY), and the annual figure for FY2025 was $80.4 million, down 2.47%.
- Shares Outstanding (Weighted Average) for Q4 2025 was $80.4 million at Idexx Laboratories, roughly flat from $80.1 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for IDXX hit a ceiling of $85.5 million in Q1 2021 and a floor of $80.1 million in Q3 2025.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $83.1 million (2023), compared with a mean of $83.1 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): grew 0.22% in 2021 and later fell 2.68% in 2025.
- Idexx Laboratories' Shares Outstanding (Weighted Average) stood at $85.2 million in 2021, then fell by 1.85% to $83.6 million in 2022, then decreased by 0.67% to $83.1 million in 2023, then dropped by 0.72% to $82.5 million in 2024, then fell by 2.47% to $80.4 million in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $80.4 million (Q4 2025), $80.1 million (Q3 2025), and $80.4 million (Q2 2025) per Business Quant data.